The global allergy diagnostics and therapeutics market is at an inflection point as rising allergic disease burden, technological advances in point-of-care testing, and rapid expansion of immunotherapy treatments reshape care pathways. Clinicians, payers, and device and drug makers are increasingly aligning around earlier, more accurate diagnosis and targeted therapies — a trend...